Low-volume surgeons can have better outcomes at certain hospital settings for open abdominal aortic repairs.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
09 2023
Historique:
received: 17 06 2022
revised: 28 03 2023
accepted: 09 04 2023
medline: 22 8 2023
pubmed: 13 5 2023
entrez: 12 5 2023
Statut: ppublish

Résumé

The volume-outcomes relationship is cross-cutting among open abdominal aortic operations, where higher-volume surgeons have better perioperative outcomes. However, there has been minimal focus on low-volume surgeons and how to improve their outcomes. This study sought to identify if there are any differences in outcomes among low-volume surgeons for open abdominal aortic surgeries by different hospital settings. We used the 2012-2019 Vascular Quality Initiative registry to identify all patients who underwent open abdominal aortic surgery for aneurysmal or aorto-iliac occlusive disease by a low-volume surgeon (<7 operations annually). We categorized high-volume hospitals using three distinct definitions: those that performed ≥10 operations annually, those with at least one high-volume surgeon, and by the number of surgeons (1-2 surgeons, 3-4 surgeons, 5-7 surgeons, and 8+ surgeons). Outcomes included 30-day perioperative mortality, overall complications, and failure-to-rescue. We compared outcomes among low-volume surgeons using univariable and multivariable logistic regressions across each of these three hospital categorizations. Among 14,110 patients who underwent open abdominal aortic surgery, 10,252 (7 3%) were performed by 1155 low-volume surgeons. Two-thirds of these patients (66%) underwent their surgery at a high-volume hospital, fewer than one-third (30%) at a hospital that had at least one high-volume surgeon, and one-half (49%) at hospitals with at least five surgeons. Among all patients operated on by low-volume surgeons, rates of 30-day mortality were 3.8%, perioperative complications were 35.3%, and failure-to-rescue were 9.9%. Low-volume surgeons operating at high-volume hospitals for aneurysmal disease had lower rates of perioperative death (adjusted odds ratio [aOR], 0.66; 95% confidence interval [CI], 0.48-0.90) and failure-to-rescue (aOR, 0.70; 95% CI, 0.50-0.98), but similar rates of complications (aOR, 1.06; 95% CI, 0.89-1.27). Similarly, patients undergoing their operation at hospitals that had at least one high-volume surgeon had lower rates of death (aOR, 0.71; 95% CI, 0.50-0.99) for aneurysmal disease. Patient outcomes among low-volume surgeons for aorto-iliac occlusive disease did not vary by hospital setting. The majority of patients undergoing open abdominal aortic surgery have a low-volume surgeon, where outcomes are slightly better for those taking place at a high-volume hospital. Focused and incentivized interventions may be needed to improve outcomes among low-volume surgeons across all practice settings.

Identifiants

pubmed: 37172621
pii: S0741-5214(23)01151-5
doi: 10.1016/j.jvs.2023.04.041
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

638-646

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Ambar Mehta (A)

Division of Cardiac, Thoracic, and Vascular Surgery, New York-Presbyterian Columbia University Medical Center, New York, NY.

Priya Patel (P)

Division of Cardiac, Thoracic, and Vascular Surgery, New York-Presbyterian Columbia University Medical Center, New York, NY; Division of General Surgery, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ.

Adham Elmously (A)

Division of Cardiac, Thoracic, and Vascular Surgery, New York-Presbyterian Columbia University Medical Center, New York, NY.

James Iannuzzi (J)

Division of Vascular and Endovascular Surgery, UCSF, San Francisco, CA.

Karan Garg (K)

Division of Vascular and Endovascular Surgery, NYU Langone Health, New York, NY.

Jeffrey Siracuse (J)

Division of Vascular and Endovascular Surgery, Boston University, Boston, MA.

Hiroo Takayama (H)

Division of Cardiac, Thoracic, and Vascular Surgery, New York-Presbyterian Columbia University Medical Center, New York, NY.

Marc L Schermerhorn (ML)

Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, MA.

Thomas F X O'Donnell (TFX)

Division of Cardiac, Thoracic, and Vascular Surgery, New York-Presbyterian Columbia University Medical Center, New York, NY.

Virendra I Patel (VI)

Division of Cardiac, Thoracic, and Vascular Surgery, New York-Presbyterian Columbia University Medical Center, New York, NY. Electronic address: vp2385@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH